Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Drug Design Development and Therapy ◽

10.2147/dddt.s110425 ◽

2016 ◽

Vol Volume 10 ◽

pp. 2353-2358 ◽

Cited By ~ 13

Author(s):

Sachio Fushida ◽

Jun Kinoshita ◽

Masahide Kaji ◽

Katsunobu Oyama ◽

Yasuo Hirono ◽

...

Keyword(s):

Gastric Cancer ◽

Valproic Acid ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Therapy ◽

Acid Versus ◽

Randomized Phase Ii ◽

Third Line Therapy ◽

Third Line

Download Full-text

Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer

OncoTargets and Therapy ◽

10.2147/ott.s83114 ◽

2015 ◽

pp. 939 ◽

Cited By ~ 4

Author(s):

Sachio Fushida ◽

Masahide Kaji ◽

Katsunobu Oyama ◽

Yasuo Hirono ◽

Hideaki Nazuka ◽

...

Keyword(s):

Gastric Cancer ◽

Valproic Acid ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

P-283 Paclitaxel plus valproic acid versus paclitaxel alone as second or third line therapy for advanced gastric cancer: a randomized phase 2 trial

Annals of Oncology ◽

10.1093/annonc/mdw199.273 ◽

2016 ◽

Vol 27 ◽

pp. ii82

Author(s):

J. Kinoshita ◽

S. Fushida ◽

M. Kaji ◽

K. Oyama ◽

Y. Hirono ◽

...

Keyword(s):

Gastric Cancer ◽

Valproic Acid ◽

Advanced Gastric Cancer ◽

Phase 2 ◽

Phase 2 Trial ◽

Line Therapy ◽

Acid Versus ◽

Third Line Therapy ◽

Third Line ◽

Randomized Phase 2

Download Full-text

A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer

Investigational New Drugs ◽

10.1007/s10637-013-0057-2 ◽

2013 ◽

Vol 32 (2) ◽

pp. 355-361 ◽

Cited By ~ 68

Author(s):

Yoon-Koo Kang ◽

Kei Muro ◽

Min-Hee Ryu ◽

Hirofumi Yasui ◽

Tomohiro Nishina ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Gastric Cancer ◽

Line Therapy ◽

Arq 197 ◽

Third Line Therapy ◽

Met Inhibitor ◽

Third Line

Download Full-text

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

Gastric Cancer ◽

10.1007/s10120-014-0420-9 ◽

2014 ◽

Vol 18 (4) ◽

pp. 824-832 ◽

Cited By ~ 60

Author(s):

Taroh Satoh ◽

Kyung Hee Lee ◽

Sun Young Rha ◽

Yasutsuna Sasaki ◽

Se Hoon Park ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

740 POSTER Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy in patients with advanced gastric cancer —interim analysis of a multicenter, randomized phase II trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81035-3 ◽

2005 ◽

Vol 3 (2) ◽

pp. 211-212

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil

Anti-Cancer Drugs ◽

10.1097/00001813-200602000-00015 ◽

2006 ◽

Vol 17 (2) ◽

pp. 225-229 ◽

Cited By ~ 45

Author(s):

Se Hoon Park ◽

Woon Kee Lee ◽

Min Chung ◽

Yuna Lee ◽

Sang Hoon Han ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.4534 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4534-4534 ◽

Cited By ~ 2

Author(s):

H. Jeung ◽

C. Im ◽

S. Rha ◽

J. Ahn ◽

S. Shin ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A randomized phase II trial of S-1-oxaliplatin versus capecitabine–oxaliplatin in advanced gastric cancer

European Journal of Cancer ◽

10.1016/j.ejca.2011.12.017 ◽

2012 ◽

Vol 48 (4) ◽

pp. 518-526 ◽

Cited By ~ 70

Author(s):

Gun Min Kim ◽

Hei-Cheul Jeung ◽

Sun Young Rha ◽

Hyo Song Kim ◽

Inkyung Jung ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer

Cancer Science ◽

10.1111/cas.13698 ◽

2018 ◽

Vol 109 (8) ◽

pp. 2567-2575 ◽

Cited By ~ 1

Author(s):

Hiroki Osumi ◽

Eiji Shinozaki ◽

Tetsuo Mashima ◽

Takeru Wakatsuki ◽

Mitsukuni Suenaga ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Wild Type ◽

Exon 2 ◽

Line Therapy ◽

Third Line Therapy ◽

Third Line ◽

Kras Exon

Download Full-text

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Annals of Oncology ◽

10.1093/annonc/mdm269 ◽

2007 ◽

Vol 18 (10) ◽

pp. 1673-1679 ◽

Cited By ~ 98

Author(s):

S. Lorenzen ◽

M. Hentrich ◽

C. Haberl ◽

V. Heinemann ◽

T. Schuster ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Gastroesophageal Junction ◽

First Line ◽

Split Dose ◽

First Line Therapy ◽

Line Therapy

Download Full-text